|
|||||||||
|
|||||||||
Welcome |
| The Tumor Vaccine Group at the University of Washington is a multidisciplinary group of investigators focused on the diagnosis, prevention and treatment of cancer with novel, immune-based therapies. Involving scientists, doctors, nurses, and patients, our translational research works to bring the most innovative treatments from the bench to the bedside and to harmonize scientific study with patient care.
Cancer immunology is an extremely new and exciting field. Scientists and research physicians are constantly gaining greater understanding about the way the immune system interacts with cancer. They are discovering and developing new, immune-based treatments that are now becoming the standard of care in addition to surgery, chemotherapy, and radiation. These treatments impact everyone who is affected by the cancer – from families and organizations in the local community to researchers and patients throughout the world. We invite you to explore the work we are doing, through scientific research and clinical trials, to further cancer’s diagnosis, treatment, and prevention. This site provides an introduction to immune therapies and our ongoing clinical trials program and pre-clinical research projects. |
The Tumor Vaccine Group |
|
|
Top Row: Greg Holt, Kathy Tietje, Vivian Goodell, Nora Disis, Jen Childs, Danelle Wallace, Meredith Slota
Middle Row: Molly Boettcher, Hailing Lu, Doreen Higgins, Lupe Salazar, Ekram Gad, Miriam Bolding Bottom Row: Tess Bayon, Vy Lai, Amy Chang, Yi Yang, Yushe Dang |
| Not Photographed: Yifeng Zhou, Ron Swensen, Eddy Park, Heidi Gray, Andrew Coveler |
Our Mission
|
|
| University of Washington South Lake Union campus. |